Feedback (LON:FDBK) Share Price Passes Above 50-Day Moving Average – Time to Sell?

Feedback plc (LON:FDBK)’s stock price passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 12.06 and traded as high as GBX 13.50. Feedback shares last traded at GBX 13.50, with a volume of 40,546 shares traded.

Feedback Stock Up 1.9%

The company has a market capitalization of £5.92 million, a P/E ratio of -0.86 and a beta of 0.77. The company has a 50-day moving average of GBX 12.06 and a two-hundred day moving average of GBX 10.65.

Feedback (LON:FDBK) last posted its quarterly earnings data on Tuesday, February 17th. The company reported GBX (3.98) earnings per share (EPS) for the quarter. Feedback had a negative return on equity of 135.17% and a negative net margin of 845.25%. As a group, equities analysts expect that Feedback plc will post -8 EPS for the current fiscal year.

Insider Activity

In other Feedback news, insider Emma Oswick (Stuart) purchased 60,459 shares of the firm’s stock in a transaction that occurred on Tuesday, December 23rd. The stock was bought at an average cost of GBX 8 per share, for a total transaction of £4,836.72. Also, insider Tom Oakley purchased 60,904 shares of the stock in a transaction that occurred on Tuesday, December 23rd. The shares were acquired at an average cost of GBX 8 per share, with a total value of £4,872.32. 7.98% of the stock is owned by company insiders.

Feedback Company Profile

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.